This topic contains a solution. Click here to go to the answer

Author Question: The nurse is providing care for a client who developed heparin-induced thrombocytopenia (HIT) during ... (Read 112 times)

D2AR0N

  • Hero Member
  • *****
  • Posts: 561
The nurse is providing care for a client who developed heparin-induced thrombocytopenia (HIT) during heparin therapy.
 
  The nurse is aware that lepirudin (Refludan) is often given to clients with this condition. Which assessment findings should the nurse report to the medical team?
  Standard Text: Select all that apply.
  1. The most recent aPTT is 2.8.
  2. The client's last stool tested positive for blood.
  3. The client is allergic to eggs.
  4. The client's spleen was removed after a motor vehicle accident 3 years ago.
  5. The client drinks 56 cups of coffee daily.

Question 2

A client's intravenous heparin drip rate will be increased at 1400. The nurse plans to draw an activated partial thromboplastin time (aPTT) at which time?
 
  1. Immediately after increasing the rate
  2. At 2000
  3. At 1530
  4. At 0800 the next morning



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macmac

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Correct Answer: 1,2
Rationale 1: Lepirudin is contraindicated if the aPTT is above 2.5.
Rationale 2: Lepirudin is contraindicated in clients who are actively bleeding.
Rationale 3: There is no contraindication to the use of lepirudin in clients with egg allergy.
Rationale 4: A surgery 3 years ago is not a contraindication to the use of lepirudin, nor is absence of the spleen.
Rationale 5: There is no contraindication to the use of lepirudin in those who drink coffee.
Global Rationale: Lepirudin is contraindicated if the aPTT is above 2.5 or if the client is actively bleeding. There is no contraindication to the use of lepirudin in clients with egg allergy or for those who drink coffee. A surgery 3 years ago is not a contraindication to the use of lepirudin, nor is absence of the spleen.

Answer to Question 2

Correct Answer: 2
Rationale 1: If drawn immediately, the aPTT will reflect the level from the lower dosage.
Rationale 2: The most accurate representation of aPTT from the new rate will occur at least 6 hours after a rate increase.
Rationale 3: At 1530, the aPTT will reflect a mix of the old rate and the new rate.
Rationale 4: Waiting until 0800 the next morning is dangerous because the heparin dose may be too high.
Global Rationale: The most accurate representation of aPTT from the new rate will occur at least 6 hours after a rate increase. If drawn immediately, the aPTT will reflect the level from the lower dosage. At 1530, the aPTT will reflect a mix of the old rate and the new rate. Waiting until 0800 the next morning is dangerous because the heparin dose may be too high.




D2AR0N

  • Member
  • Posts: 561
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library